Polaryx Therapeutics, Inc. (PLYX) stock forecast and price target
Price $1.77 · data as of November 13, 2026
12-month price target
Average target$7.50
Upside / downside+323.7%
Analysts4
ConsensusStrong buy
Low $6.00Average $7.50High $10.00
Gold marker: average target · white marker: today’s price ($1.77)
Analyst ratings
Strong buy 1Buy 3Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.23 | — | $0 |
| Next fiscal year ends December 31, 2027 | $-0.28 | — | $0 |
| Next quarter ends December 31, 2026 | $-0.08 | — | $0 |
| Quarter after ends March 31, 2027 | $-0.07 | — | $0 |
Consensus of the analysts covering Polaryx Therapeutics, updated daily.
Frequently asked questions
What is the Polaryx Therapeutics stock price target?
The average 12-month target from 4 analysts is $7.50, 323.7% above the current price of $1.77 Targets range from $6.00 to $10.00.
Is Polaryx Therapeutics a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 3 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Polaryx Therapeutics expected to earn?
Analysts expect EPS of $-0.23 for the fiscal year ending December 31, 2026 and $-0.28 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.